Diagnostic Green published a systematic review and meta-analysis evaluating intraoperative indocyanine green versus clinical assessment for free flap failure prevention.
Public source
Publisher name
Public post
Intraoperative indocyanine green versus clinical assessment for prevention of free flap failure: A systematic review and meta-analysis Background: Both total and partial…
Company
Diagnostic Green
The Diagnostic Green Company is the leading provider of trusted high quality fluorescence pharmaceutical products.
- Industry
- Pharmaceutical Manufacturing
- Location
- Athlone, IE
- Company size
- 11–50 employees
About Diagnostic Green
Diagnostic Green is a global manufacturer of the pharmaceutical VERDYE (Indocyanine Green, ICG) and the IC-Flow Imaging System (fluorescence camera). Our vision at Diagnostic Green is that fluorescence imaging will become the standard of care in daily diagnostics in order to improve the clinical outcome. Therefore our focus on superior quality and availability of our products is a vital component of the corporate culture of Diagnostic Green.
See moreLatest activity
Latest activity from Diagnostic Green
6 signals
Research & Knowledge
Diagnostic Green published a study on the surgical techniques and outcomes of hepatopancreatoduodenectomy using indocyanine green fluorescence imaging for Bismuth type IIIb perihilar cholangiocarcinoma in a patient with right-sided ligamentum teres.
Presence & Recognition
Diagnostic Green is attending the Joint Meeting of ESPRAS & Swiss Plastic Surgery 2026 in Bern, Switzerland, on 3-5 September.
Presence & Recognition
Diagnostic Green attended the International Society for Fluorescence Guided Surgery Congreso Capítulo LATAM in Panamá at the Pacífica Salud Hospital Punta Pacífica.
Discover more
Similar signals
Similar public activity from other companies.
Research & Knowledge
Kent Imaging
Kent Imaging published a case study on the use of SnapshotNIR during the early post-operative period for a patient with uncontrolled diabetes and PAD undergoing a reverse sural artery flap.
Research & Knowledge
Hugel Aesthetics
Hugel Aesthetics published the 2025 edition of the ASPS Annual Statistics Report, which confirms that 75% of surveyed surgeons named restoration after life changes as the leading reason patients seek plastic surgery.
Research & Knowledge
POLYTECH Health & Aesthetics
POLYTECH Health & Aesthetics published research showing that MESMO microtextured surface with Open Gas Diffusion Surface (GDS) finishing technology supports tissue integration and reduces the risk of implant displacement.
Research & Knowledge
Plexāā | Creators of BLOOM⁴³
Plexāā | Creators of BLOOM⁴³ Founder and CEO Dr Saahil Mehta MD FRCS(Plast) discussed the research behind thermal preconditioning technology and how it helped reduce skin necrosis by 24% in a randomized controlled trial.
Research & Knowledge
botiss biomaterials